These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8356908)

  • 1. Role of glutathione in cellular resistance to alkylating agents.
    Colvin OM; Friedman HS; Gamcsik MP; Fenselau C; Hilton J
    Adv Enzyme Regul; 1993; 33():19-26. PubMed ID: 8356908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
    Dirven HA; van Ommen B; van Bladeren PJ
    Cancer Res; 1994 Dec; 54(23):6215-20. PubMed ID: 7954469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
    Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione conjugation with phosphoramide mustard and cyclophosphamide. A mechanistic study using tandem mass spectrometry.
    Yuan ZM; Smith PB; Brundrett RB; Colvin M; Fenselau C
    Drug Metab Dispos; 1991; 19(3):625-9. PubMed ID: 1680629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.
    Alaoui-Jamali MA; Panasci L; Centurioni GM; Schecter R; Lehnert S; Batist G
    Cancer Chemother Pharmacol; 1992; 30(5):341-7. PubMed ID: 1505071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro.
    McGown AT; Fox BW
    Cancer Chemother Pharmacol; 1986; 17(3):223-6. PubMed ID: 3742706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells.
    Ripple M; Mulcahy RT; Wilding G
    J Urol; 1993 Jul; 150(1):209-14. PubMed ID: 8510259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic mechanisms of resistance to alkylating agents in tumor cells and normal tissues.
    Colvin M; Russo JE; Hilton J; Dulik DM; Fenselau C
    Adv Enzyme Regul; 1988; 27():211-21. PubMed ID: 3074628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione conjugation of the cytostatic drug ifosfamide and the role of human glutathione S-transferases.
    Dirven HA; Megens L; Oudshoorn MJ; Dingemanse MA; van Ommen B; van Bladeren PJ
    Chem Res Toxicol; 1995; 8(7):979-86. PubMed ID: 8555414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of multidrug resistance protein 1 (MRP1) and glutathione S-transferase A1-1 in alkylating agent resistance. Kinetics of glutathione conjugate formation and efflux govern differential cellular sensitivity to chlorambucil versus melphalan toxicity.
    Paumi CM; Ledford BG; Smitherman PK; Townsend AJ; Morrow CS
    J Biol Chem; 2001 Mar; 276(11):7952-6. PubMed ID: 11115505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell heterogeneity: impact on mechanisms of therapeutic drug resistance.
    Richardson ME; Siemann DW
    Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):789-95. PubMed ID: 9369124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells.
    Chen G; Waxman DJ
    Biochem Pharmacol; 1994 Mar; 47(6):1079-87. PubMed ID: 8147907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of melphalan by rat liver microsomal glutathione S-transferase.
    Zhang J; Ye Z; Lou Y
    Chem Biol Interact; 2005 Apr; 152(2-3):101-6. PubMed ID: 15840383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
    Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
    PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers.
    Ford JM; Hait WN; Matlin SA; Benz CC
    Cancer Lett; 1991 Jan; 56(1):85-94. PubMed ID: 2004358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells.
    Letourneau S; Greenbaum M; Cournoyer D
    Hum Gene Ther; 1996 May; 7(7):831-40. PubMed ID: 8860835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-transit melanoma: the role of alkylating-agent resistance in regional therapy.
    Grubbs EG; Abdel-Wahab O; Cheng TY; Abdel-Wahab Z; Peterson B; Pruitt SK; Colvin OM; Friedman HS; Tyler DS
    J Am Coll Surg; 2004 Sep; 199(3):419-27. PubMed ID: 15325612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents.
    Britten RA; Green JA; Warenius HM
    Int J Radiat Oncol Biol Phys; 1992; 24(3):527-31. PubMed ID: 1399740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human mu or alpha class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents.
    Townsend AJ; Tu CP; Cowan KH
    Mol Pharmacol; 1992 Feb; 41(2):230-6. PubMed ID: 1538704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines.
    Buller AL; Clapper ML; Tew KD
    Mol Pharmacol; 1987 Jun; 31(6):575-8. PubMed ID: 3600602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.